Evidence map›Paper›PMID 31904091›Full record

ArticleBioscience reports2020

Identification of 13 novel USH2A mutations in Chinese retinitis pigmentosa and Usher syndrome patients by targeted next-generation sequencing.

Ling-Hui Qu, Xin Jin, Yan-Ling Long, Jia-Yun Ren, Chuang-Huang Weng, Hai-Wei Xu, Yong Liu, Xiao-Hong Meng, Shi-Ying Li, Zheng-Qin Yin

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ling-Hui QuDepartment of Ophthalmology, The 74th Army Group Hospital, Guangzhou 510318, China.
Xin JinDepartment of Ophthalmology, General Hospital of Chinese People's Liberation Army, Beijing 100853, China.
Yan-Ling LongSouthwest Hospital/Southwest Eye Hospital, Third Military Medical University, (Army Medical University), Chongqing 400038, China.
Jia-Yun RenSouthwest Hospital/Southwest Eye Hospital, Third Military Medical University, (Army Medical University), Chongqing 400038, China.
Chuang-Huang WengSouthwest Hospital/Southwest Eye Hospital, Third Military Medical University, (Army Medical University), Chongqing 400038, China.
Hai-Wei XuSouthwest Hospital/Southwest Eye Hospital, Third Military Medical University, (Army Medical University), Chongqing 400038, China.
Yong LiuSouthwest Hospital/Southwest Eye Hospital, Third Military Medical University, (Army Medical University), Chongqing 400038, China.
Xiao-Hong MengSouthwest Hospital/Southwest Eye Hospital, Third Military Medical University, (Army Medical University), Chongqing 400038, China.
Shi-Ying LiSouthwest Hospital/Southwest Eye Hospital, Third Military Medical University, (Army Medical University), Chongqing 400038, China.
Zheng-Qin YinSouthwest Hospital/Southwest Eye Hospital, Third Military Medical University, (Army Medical University), Chongqing 400038, China.
Army Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe USH2A gene encodes usherin, a basement membrane protein that is involved in the development and homeostasis of the inner ear and retina. Mutations in USH2A are linked to Usher syndrome type II (USH II) and non-syndromic retinitis pigmentosa (RP). Molecular diagnosis can provide insight into the pathogenesis of these diseases, facilitate clinical diagnosis, and identify individuals who can most benefit from gene or cell replacement therapy. Here, we report 21 pathogenic mutations in the USH2A gene identified in 11 Chinese families by using the targeted next-generation sequencing (NGS) technology.

methodsIn all, 11 unrelated Chinese families were enrolled, and NGS was performed to identify mutations in the USH2A gene. Variant analysis, Sanger validation, and segregation tests were utilized to validate the disease-causing mutations in these families.

resultsWe identified 21 pathogenic mutations, of which 13, including 5 associated with non-syndromic RP and 8 with USH II, have not been previously reported. The novel variants segregated with disease phenotype in the affected families and were absent from the control subjects. In general, visual impairment and retinopathy were consistent between the USH II and non-syndromic RP patients with USH2A mutations.

conclusionsThese findings provide a basis for investigating genotype-phenotype relationships in Chinese USH II and RP patients and for clarifying the pathophysiology and molecular mechanisms of the diseases associated with USH2A mutations.

Indexed as

DNA Mutational AnalysisHigh-Throughput Nucleotide SequencingAdultAsian PeopleCase-Control StudiesChinaExtracellular Matrix ProteinsFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHeredityHumansMaleMiddle AgedPedigreePhenotypeExtracellular Matrix ProteinsUSH2A protein, humanNon-syndromic retinitis pigmentosaUSH2A geneUsher syndrome

Identifiers

PMID31904091
PMCPMC6974426
OpenAlexW3002493307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.